The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1.

Autor: Yue Xi1,2, Yanping Li3, Pengfei Xu1, Sihan Li1, Zhengsheng Liu4, Hung-chun Tung1, Xinran Cai1, Jingyuan Wang1, Haozhe Huang1, Menglin Wang4, Meishu Xu1, Songrong Ren1, Song Li1, Min Zhang1, Lee, Yong J.5, Leaf Huang4, Da Yang1, Jinhan He3 jinhanhe@scu.edu.cn, Zhiying Huang2 hzhiying@mail.sysu.edu.cn, Wen Xie1,6 wex6@pitt.edu
Zdroj: Science Advances. 9/3/2021, Vol. 7 Issue 36, p1-14. 14p.
Databáze: Academic Search Ultimate